Introduction: This study aims to investigate the correlation between interleukin-6 (IL-6) (-174 G>C) and tumor necrosis factor-alpha (TNF-α) (-238 G>A) cytokine gene polymorphisms and diabetic foot infection (DFI). Materials and Methods:This study involved the collection of blood samples from a total of 207 participants who were grouped as follows: a control group of 60 healthy individuals, a group of 60 patients with type 2 diabetes mellitus (T2DM) but without diabetic foot ulcer (DFU), and a group of 87 patients with DFI.The genotypes of IL-6 (-174 G>C) and TNF-α (-238 G>A) polymorphisms were determined using real-time PCR and the TaqMan method. Results:The findings indicate that there were no statistically significant variations in the distribution of IL-6 (-174 G>C) and TNF-α (-238 G>A) polymorphisms genotypes among individuals with T2DM who had DFI, individuals with T2DM without DFU, and the control group (p> 0.05).A higher prevalence of osteomyelitis was detected in patients with DFI possessing the GG genotype (53.1%) of the IL-6 (-174 G>C) polymorphism, compared to those with the mutant genotypes (GC + CC) (28.9%) (p= 0.024).The study revealed a higher prevalence of venous insufficiency (VI) in individuals with DFI possessing TNF-α (-238 G>A) GA genotype compared to those with the GG genotype (80.0%, 24.4%, respectively) (p= 0.007).The study indicated that patients with DFI possessing the TNF-α (-238 G>A) GA genotype had a higher mean body mass index (BMI) compared to those with the GG genotype (p= 0.012). Conclusion:The study has demonstrated that the IL-6 (-174 G>C) and TNF-α (-238 G>A) polymorphisms cannot serve as reliable indicators for determining an individual's vulnerability to DFI and T2DM.The IL-6 (-174 G>C) polymorphism's GG genotype exhibited a significant association with osteomyelitis in patients with DFI.Findings suggest that individuals with the TNF-α (-238 G>A) GA genotype in DFI patients may experience VI and higher average BMI than patients with the GG genotype.
No takes yet. Share an insight, caveat, or question.
Sarıkaya et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: